metoprolol tartrate 37.5 MG Oral Tablet

RxCUI
1606347
RxNorm name
metoprolol tartrate 37.5 MG Oral Tablet
Display name
Metoprolol (Oral Pill)
Full name
metoprolol tartrate 37.5 MG Oral Tablet
Term type
SCD
Status
Active
Strength
37.5 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-11-14 08:31:49

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
042015
Active start
042015
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
metoprolol tartrate37.5 MG / 1 EACHmetoprololmetoprolol tartrate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
metoprolol6918

Source Vocabulary Codes#

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
0378-4593-010378-4593Metoprolol Tartrate metoprolol tartrateMylan Pharmaceuticals Inc.ANDA076704
52817-251-1052817-251METOPROLOL TARTRATE METOPROLOL TARTRATETRUPHARMA LLCANDA200981
52817-358-1052817-358Metoprolol Tartrate Metoprolol TartrateTruPharma LLCANDA200981
52817-358-5052817-358Metoprolol Tartrate Metoprolol TartrateTruPharma LLCANDA200981
59651-758-0159651-758Metoprolol Tartrate Metoprolol TartrateAurobindo Pharma LimitedANDA077739
72888-101-0172888-101METOPROLOL TARTRATE METOPROLOL TARTRATEAdvagen Pharma LimitedANDA200981
72888-101-0572888-101METOPROLOL TARTRATE METOPROLOL TARTRATEAdvagen Pharma LimitedANDA200981
72888-209-0172888-209METOPROLOL TARTRATE METOPROLOL TARTRATEAdvagen Pharma LtdANDA200981
72888-209-0572888-209METOPROLOL TARTRATE METOPROLOL TARTRATEAdvagen Pharma LtdANDA200981
87063-185-0187063-185METOPROLOL TARTRATE METOPROLOL TARTRATEASCLEMED USA INC.ANDA200981
87063-185-3087063-185METOPROLOL TARTRATE METOPROLOL TARTRATEASCLEMED USA INC.ANDA200981
87063-185-6087063-185METOPROLOL TARTRATE METOPROLOL TARTRATEASCLEMED USA INC.ANDA200981
87063-185-9087063-185METOPROLOL TARTRATE METOPROLOL TARTRATEASCLEMED USA INC.ANDA200981

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA0767040378-4593Metoprolol Tartrate metoprolol tartrateANDAMylan Pharmaceuticals Inc.
ANDA20098152817-251METOPROLOL TARTRATE METOPROLOL TARTRATEANDATRUPHARMA LLC
ANDA07773959651-758Metoprolol Tartrate Metoprolol TartrateANDAAurobindo Pharma Limited

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 18 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00378459301rxnav_ndcsyes
00378459305rxnav_ndcsyes
52817025110rxnav_ndcsyes
52817035810rxnav_ndcsyes
52817035850rxnav_ndcsyes
59651075801rxnav_ndcsyes
72888002201rxnav_ndcsyes
72888010101rxnav_ndcsyes
72888010105rxnav_ndcsyes
72888020901rxnav_ndcsyes
72888020905rxnav_ndcsyes
87063018501rxnav_ndcsyes
87063018530rxnav_ndcsyes
87063018560rxnav_ndcsyes
87063018590rxnav_ndcsyes
00378459377rxnav_historical
00378459391rxnav_historical
72888002205rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 7 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
METOPROLOL TARTRATEMETOPROLOL TARTRATEAdvagen Pharma Ltd3ecff825-34ea-4535-b935-627bf2c13d932026-10-15Warnings, Adverse reactionsExact identifier
ndc (package): 72888-209-01
ndc (package): 72888-209-05
ndc (product): 72888-209
ndc11 (package): 72888020901
ndc11 (package): 72888020905
rxcui: 1606347
METOPROLOL TARTRATEMETOPROLOL TARTRATEASCLEMED USA INC.df3492c3-b71a-40d8-838b-031ebca969d82026-05-18Warnings, Adverse reactionsExact identifier
ndc (package): 87063-185-30
ndc (package): 87063-185-01
ndc (package): 87063-185-60
ndc (package): 87063-185-90
ndc (product): 87063-185
ndc11 (package): 87063018560
ndc11 (package): 87063018590
ndc11 (package): 87063018501
ndc11 (package): 87063018530
rxcui: 1606347
METOPROLOL TARTRATEMETOPROLOL TARTRATEAdvagen Pharma Limiteda401fe31-d51a-49d9-a062-c9d22088db562026-01-13Warnings, Adverse reactionsExact identifier
ndc (package): 72888-101-05
ndc (package): 72888-101-01
ndc (product): 72888-101
ndc11 (package): 72888010101
ndc11 (package): 72888010105
rxcui: 1606347
Metoprolol TartrateMETOPROLOL TARTRATETruPharma LLC52c822f2-4a71-4ab2-a470-58074622846a2024-12-15Warnings, Adverse reactionsExact identifier
ndc (package): 52817-358-10
ndc (package): 52817-358-50
ndc (product): 52817-358
ndc11 (package): 52817035850
ndc11 (package): 52817035810
rxcui: 1606347
METOPROLOL TARTRATEMETOPROLOL TARTRATETRUPHARMA LLC92ab5942-823d-43aa-8e7a-56844ab8946f2024-09-18Warnings, Adverse reactionsExact identifier
ndc (package): 52817-251-10
ndc (product): 52817-251
ndc11 (package): 52817025110
rxcui: 1606347
Metoprolol TartrateMETOPROLOL TARTRATEAurobindo Pharma Limitedac4ac150-d3e6-4bd1-8a4a-7d63fade3e492024-02-13Warnings, Adverse reactionsExact identifier
ndc (package): 59651-758-01
ndc (product): 59651-758
ndc11 (package): 59651075801
rxcui: 1606347
Metoprolol TartrateMETOPROLOL TARTRATEMylan Pharmaceuticals Inc.809c6386-0039-42ff-a03e-e42733e229b82024-01-31Warnings, Adverse reactionsExact identifier
ndc (package): 0378-4593-01
ndc (product): 0378-4593
ndc11 (package): 00378459301
rxcui: 1606347

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 7 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
809c6386-0039-42ff-a03e-e42733e229b8metoprolol tartrate 37.5 MG Oral Tablet [PSN] · metoprolol tartrate 37.5 MG Oral Tablet [SCD]231These highlights do not include all the information needed to use METOPROLOL TARTRATE TABLETS safely and effectively. See full prescribing information for METOPROLOL TARTRATE TABLETS . METOPROLOL TARTRATE tablets, for oral use Initial U.S. Approval: 199220240131
52c822f2-4a71-4ab2-a470-58074622846ametoprolol tartrate 37.5 MG Oral Tablet [PSN] · metoprolol tartrate 37.5 MG Oral Tablet [SCD]27METOPROLOL TARTRATE TABLETS, USP TruPharma LLC R x only20241215
a401fe31-d51a-49d9-a062-c9d22088db56metoprolol tartrate 37.5 MG Oral Tablet [PSN] · metoprolol tartrate 37.5 MG Oral Tablet [SCD]26These highlights do not include all the information needed to use METOPROLOL TARTRATE TABLETS safely and effectively. See full prescribing information for METOPROLOL TARTRATE TABLETS. METOPROLOL TARTRATE tablets, for oral use Initial U.S. Approval: 199220260113
ac4ac150-d3e6-4bd1-8a4a-7d63fade3e49metoprolol tartrate 37.5 MG Oral Tablet [PSN] · metoprolol tartrate 37.5 MG Oral Tablet [SCD]23These highlights do not include all the information needed to use METOPROLOL TARTRATE TABLETS safely and effectively. See full prescribing information for METOPROLOL TARTRATE TABLETS. METOPROLOL TARTRATE tablets, for oral use Initial U.S. Approval: 199220240213
3ecff825-34ea-4535-b935-627bf2c13d93metoprolol tartrate 37.5 MG Oral Tablet [PSN] · metoprolol tartrate 37.5 MG Oral Tablet [SCD]22These highlights do not include all the information needed to use METOPROLOL TARTRATE TABLETS safely and effectively. See full prescribing information for METOPROLOL TARTRATE TABLETS. METOPROLOL TARTRATE tablets, for oral use Initial U.S. Approval: 199220250912
df3492c3-b71a-40d8-838b-031ebca969d8metoprolol tartrate 37.5 MG Oral Tablet [PSN] · metoprolol tartrate 37.5 MG Oral Tablet [SCD]21These highlights do not include all the information needed to use METOPROLOL TARTRATE TABLETS safely and effectively. See full prescribing information for METOPROLOL TARTRATE TABLETS. METOPROLOL TARTRATE tablets, for oral use Initial U.S. Approval: 199220260518
92ab5942-823d-43aa-8e7a-56844ab8946fmetoprolol tartrate 37.5 MG Oral Tablet [PSN] · metoprolol tartrate 37.5 MG Oral Tablet [SCD]21These highlights do not include all the information needed to use METOPROLOL TARTRATE TABLETS safely and effectively. See full prescribing information for METOPROLOL TARTRATE TABLETS. METOPROLOL TARTRATE tablets, for oral use Initial U.S. Approval: 199220240918

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
3ecff825-34ea-4535-b935-627bf2c13d93These highlights do not include all the information needed to use METOPROLOL TARTRATE TABLETS safely and effectively. See full prescribing information for METOPROLOL TARTRATE TABLETS. METOPROLOL TARTRATE tablets, for oral use Initial U.S. Approval: 1992Advagen Pharma Ltd | Rubicon Research Limited | Axxelent Pharma Science Private Limited20261015
df3492c3-b71a-40d8-838b-031ebca969d8These highlights do not include all the information needed to use METOPROLOL TARTRATE TABLETS safely and effectively. See full prescribing information for METOPROLOL TARTRATE TABLETS. METOPROLOL TARTRATE tablets, for oral use Initial U.S. Approval: 1992ASCLEMED USA INC. | ASCLEMED USA INC. DBA ENOVACHEM20260518
a401fe31-d51a-49d9-a062-c9d22088db56These highlights do not include all the information needed to use METOPROLOL TARTRATE TABLETS safely and effectively. See full prescribing information for METOPROLOL TARTRATE TABLETS. METOPROLOL TARTRATE tablets, for oral use Initial U.S. Approval: 1992Advagen Pharma Limited | Rubicon Research Limited20260113
3ecff825-34ea-4535-b935-627bf2c13d93These highlights do not include all the information needed to use METOPROLOL TARTRATE TABLETS safely and effectively. See full prescribing information for METOPROLOL TARTRATE TABLETS. METOPROLOL TARTRATE tablets, for oral use Initial U.S. Approval: 1992Advagen Pharma Ltd | Rubicon Research Limited20250912
52c822f2-4a71-4ab2-a470-58074622846aMETOPROLOL TARTRATE TABLETS, USP TruPharma LLC R x onlyTruPharma LLC | Rubicon Research Private Limited | Rubicon Research Private Limited.20241215
92ab5942-823d-43aa-8e7a-56844ab8946fThese highlights do not include all the information needed to use METOPROLOL TARTRATE TABLETS safely and effectively. See full prescribing information for METOPROLOL TARTRATE TABLETS. METOPROLOL TARTRATE tablets, for oral use Initial U.S. Approval: 1992TRUPHARMA LLC | Rubicon Research Private Limited20240918
ac4ac150-d3e6-4bd1-8a4a-7d63fade3e49These highlights do not include all the information needed to use METOPROLOL TARTRATE TABLETS safely and effectively. See full prescribing information for METOPROLOL TARTRATE TABLETS. METOPROLOL TARTRATE tablets, for oral use Initial U.S. Approval: 1992Aurobindo Pharma Limited20240213
809c6386-0039-42ff-a03e-e42733e229b8These highlights do not include all the information needed to use METOPROLOL TARTRATE TABLETS safely and effectively. See full prescribing information for METOPROLOL TARTRATE TABLETS . METOPROLOL TARTRATE tablets, for oral use Initial U.S. Approval: 1992Mylan Pharmaceuticals Inc.20240131

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC07ABBeta blocking agents, selectiveATC1-4metoprolol
FDASPLN0000175556beta-Adrenergic BlockerEPChas_epcmetoprolol
FDASPLN0000000161Adrenergic beta-AntagonistsMOAhas_moametoprolol
MEDRTD008790MetoprololCHEMhas_ingredientmetoprolol
MEDRTD008790MetoprololCHEMhas_ingredientmetoprolol tartrate
MEDRTD000787Angina PectorisDISEASEmay_treatmetoprolol tartrate
MEDRTD000787Angina PectorisDISEASEmay_treatmetoprolol
MEDRTD001281Atrial FibrillationDISEASEmay_treatmetoprolol tartrate
MEDRTD001281Atrial FibrillationDISEASEmay_treatmetoprolol
MEDRTD001282Atrial FlutterDISEASEmay_treatmetoprolol tartrate
MEDRTD001282Atrial FlutterDISEASEmay_treatmetoprolol
MEDRTD004342Drug HypersensitivityDISEASEci_withmetoprolol tartrate
MEDRTD006333Heart FailureDISEASEci_withmetoprolol tartrate
MEDRTD006333Heart FailureDISEASEmay_treatmetoprolol
MEDRTD006333Heart FailureDISEASEci_withmetoprolol
MEDRTD006333Heart FailureDISEASEmay_treatmetoprolol tartrate
MEDRTD006973HypertensionDISEASEmay_treatmetoprolol
MEDRTD006973HypertensionDISEASEmay_treatmetoprolol tartrate
MEDRTD007022HypotensionDISEASEci_withmetoprolol
MEDRTD007022HypotensionDISEASEci_withmetoprolol tartrate
MEDRTD009203Myocardial InfarctionDISEASEmay_treatmetoprolol tartrate
MEDRTD009203Myocardial InfarctionDISEASEmay_treatmetoprolol
MEDRTD011247PregnancyDISEASEci_withmetoprolol tartrate
MEDRTD011247PregnancyDISEASEci_withmetoprolol
MEDRTD011654Pulmonary EdemaDISEASEci_withmetoprolol tartrate
MEDRTD011654Pulmonary EdemaDISEASEci_withmetoprolol
MEDRTD012770Shock, CardiogenicDISEASEci_withmetoprolol tartrate
MEDRTD012770Shock, CardiogenicDISEASEci_withmetoprolol
MEDRTD012804Sick Sinus SyndromeDISEASEci_withmetoprolol tartrate
MEDRTD012804Sick Sinus SyndromeDISEASEci_withmetoprolol
MEDRTD013617Tachycardia, SupraventricularDISEASEmay_treatmetoprolol
MEDRTD013617Tachycardia, SupraventricularDISEASEmay_treatmetoprolol tartrate
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatmetoprolol
MEDRTD017180Tachycardia, VentricularDISEASEmay_treatmetoprolol tartrate
MEDRTD014693Ventricular FibrillationDISEASEmay_treatmetoprolol
MEDRTD014693Ventricular FibrillationDISEASEmay_treatmetoprolol tartrate
MEDRTN0000009923Adrenergic beta1-AntagonistsMOAhas_moametoprolol tartrate
MEDRTN0000009923Adrenergic beta1-AntagonistsMOAhas_moametoprolol
MEDRTN0000008329Cardiac Rate AlterationPEci_pemetoprolol tartrate
MEDRTN0000008329Cardiac Rate AlterationPEci_pemetoprolol
MEDRTN0000008330Cardiac Rhythm AlterationPEci_pemetoprolol tartrate
MEDRTN0000008330Cardiac Rhythm AlterationPEci_pemetoprolol
MEDRTN0000178477Decreased Blood PressurePEhas_pemetoprolol tartrate
MEDRTN0000178477Decreased Blood PressurePEhas_pemetoprolol
MEDRTN0000009756Negative ChronotropyPEhas_pemetoprolol tartrate
MEDRTN0000009756Negative ChronotropyPEhas_pemetoprolol
MEDRTN0000009757Negative InotropyPEhas_pemetoprolol
MEDRTN0000009757Negative InotropyPEhas_pemetoprolol tartrate
MEDRTN0000000026Hepatic MetabolismPKsite_of_metabolismmetoprolol tartrate
MEDRTN0000000026Hepatic MetabolismPKsite_of_metabolismmetoprolol

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH37.5 MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESANDAANDA076704
CODESANDAANDA077739
CODESANDAANDA200981
CODESVUID4035459
NAMESPrescribable Synonymmetoprolol tartrate 37.5 MG Oral Tablet
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceVeterans Health Administration National Drug File